Topiramate (Topamax) for migraine prevention

American Family Physician

Volumn 72, Issue 8, 2005, Pages 1563-1565

  Huntington, Jane ^a   Yuan, Carrie L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; PROPRANOLOL; RIBOFLAVIN; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT;

BICARBONATE BLOOD LEVEL; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG EXCRETION; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; LANGUAGE DISABILITY; MEMORY DISORDER; MENTAL CONCENTRATION; MIGRAINE; NAUSEA; NEPHROLITHIASIS; PARESTHESIA; SHORT SURVEY; SIDE EFFECT; TABLET; WEIGHT REDUCTION;

EID: 30744447920     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Topamax (package insert). Titusville, N.J.: Ortho-McNeil Neurologics, 2005. Accessed online July 18, 2005, at: http://www.orthomcneil.com/products/pi/ pdfs/tpamax.pdf.
2. Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004;61:490-5.
3. Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;291:965-73.
4. Diener HC, Tfelt-Hansen P, Dahlof C, Lainez MJ, Sandrini G, Wang SJ, et al. Topiramate in migraine prophylaxis-results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004;251:943-50.
5. Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev 2004;(3):CD003226.
6. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998;50:466-70.